Patent ID: 9089602
Filing Date: 2015-07-28
Classification: A61K,A61P

Abstract:
1. A stable therapeutic composition comprising an electro-activated solution, wherein the electro-activated solution has an oxidation-reduction potential (ORP) in the range between −500 mV and −900 mV for a period of at least 12 months and a pH in the range between 3.2 and 4.5, and the composition comprises: Ascorbic acid 83.6-95.5 g/L; Magnesium Sulphate hexahydrate 57.1-64.7 g/L; 2-diethylaminoaceto,xylidide 31.5-37.5 g/L; Niacinamide 9.4-10.7 g/L; Pyridoxin HCL 9.4-10.7 g/L; Riboflavin-5-phosphate sodium 0.18-0.2 g/L; Thiamin HCL 5.75-6.5 g/L; Cyanocobalamin crystalline 0.17-0.2 g/L; and Electrochemically activated water+.